The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Closed System Transmission Market Research Report 2025
Synopsis
The global Drug Closed System Transmission market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Drug Closed System Transmission is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Closed System Transmission is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Drug Closed System Transmission include Equashield, BD Medical, Teva Medical, ICU Medical, Corvida Medical and B. Braun, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Closed System Transmission, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Closed System Transmission.
Report Scope
The Drug Closed System Transmission market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Closed System Transmission market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Closed System Transmission manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Equashield
BD Medical
Teva Medical
ICU Medical
Corvida Medical
B. Braun
Segment by Type
Closed Vial Access Device
Closed Syringe Safety Device
Closed Bag/Line Access Device
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Closed System Transmission manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Closed System Transmission in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Drug Closed System Transmission market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Drug Closed System Transmission is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Closed System Transmission is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Drug Closed System Transmission include Equashield, BD Medical, Teva Medical, ICU Medical, Corvida Medical and B. Braun, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Closed System Transmission, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Closed System Transmission.
Report Scope
The Drug Closed System Transmission market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Closed System Transmission market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Closed System Transmission manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Equashield
BD Medical
Teva Medical
ICU Medical
Corvida Medical
B. Braun
Segment by Type
Closed Vial Access Device
Closed Syringe Safety Device
Closed Bag/Line Access Device
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Closed System Transmission manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Closed System Transmission in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drug Closed System Transmission Market Overview
1.1 Product Overview and Scope of Drug Closed System Transmission
1.2 Drug Closed System Transmission Segment by Type
1.2.1 Global Drug Closed System Transmission Market Value Comparison by Type (2024-2030)
1.2.2 Closed Vial Access Device
1.2.3 Closed Syringe Safety Device
1.2.4 Closed Bag/Line Access Device
1.3 Drug Closed System Transmission Segment by Application
1.3.1 Global Drug Closed System Transmission Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drug Closed System Transmission Market Size Estimates and Forecasts
1.4.1 Global Drug Closed System Transmission Revenue 2019-2030
1.4.2 Global Drug Closed System Transmission Sales 2019-2030
1.4.3 Global Drug Closed System Transmission Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Closed System Transmission Market Competition by Manufacturers
2.1 Global Drug Closed System Transmission Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Closed System Transmission Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Closed System Transmission Average Price by Manufacturers (2019-2024)
2.4 Global Drug Closed System Transmission Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Closed System Transmission, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Closed System Transmission, Product Type & Application
2.7 Drug Closed System Transmission Market Competitive Situation and Trends
2.7.1 Drug Closed System Transmission Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Closed System Transmission Players Market Share by Revenue
2.7.3 Global Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Closed System Transmission Retrospective Market Scenario by Region
3.1 Global Drug Closed System Transmission Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Closed System Transmission Global Drug Closed System Transmission Sales by Region: 2019-2030
3.2.1 Global Drug Closed System Transmission Sales by Region: 2019-2024
3.2.2 Global Drug Closed System Transmission Sales by Region: 2025-2030
3.3 Global Drug Closed System Transmission Global Drug Closed System Transmission Revenue by Region: 2019-2030
3.3.1 Global Drug Closed System Transmission Revenue by Region: 2019-2024
3.3.2 Global Drug Closed System Transmission Revenue by Region: 2025-2030
3.4 North America Drug Closed System Transmission Market Facts & Figures by Country
3.4.1 North America Drug Closed System Transmission Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Closed System Transmission Sales by Country (2019-2030)
3.4.3 North America Drug Closed System Transmission Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug Closed System Transmission Market Facts & Figures by Country
3.5.1 Europe Drug Closed System Transmission Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Closed System Transmission Sales by Country (2019-2030)
3.5.3 Europe Drug Closed System Transmission Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Closed System Transmission Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Closed System Transmission Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Closed System Transmission Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Closed System Transmission Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug Closed System Transmission Market Facts & Figures by Country
3.7.1 Latin America Drug Closed System Transmission Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Closed System Transmission Sales by Country (2019-2030)
3.7.3 Latin America Drug Closed System Transmission Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Closed System Transmission Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Closed System Transmission Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Closed System Transmission Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Closed System Transmission Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Closed System Transmission Sales by Type (2019-2030)
4.1.1 Global Drug Closed System Transmission Sales by Type (2019-2024)
4.1.2 Global Drug Closed System Transmission Sales by Type (2025-2030)
4.1.3 Global Drug Closed System Transmission Sales Market Share by Type (2019-2030)
4.2 Global Drug Closed System Transmission Revenue by Type (2019-2030)
4.2.1 Global Drug Closed System Transmission Revenue by Type (2019-2024)
4.2.2 Global Drug Closed System Transmission Revenue by Type (2025-2030)
4.2.3 Global Drug Closed System Transmission Revenue Market Share by Type (2019-2030)
4.3 Global Drug Closed System Transmission Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Closed System Transmission Sales by Application (2019-2030)
5.1.1 Global Drug Closed System Transmission Sales by Application (2019-2024)
5.1.2 Global Drug Closed System Transmission Sales by Application (2025-2030)
5.1.3 Global Drug Closed System Transmission Sales Market Share by Application (2019-2030)
5.2 Global Drug Closed System Transmission Revenue by Application (2019-2030)
5.2.1 Global Drug Closed System Transmission Revenue by Application (2019-2024)
5.2.2 Global Drug Closed System Transmission Revenue by Application (2025-2030)
5.2.3 Global Drug Closed System Transmission Revenue Market Share by Application (2019-2030)
5.3 Global Drug Closed System Transmission Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Equashield
6.1.1 Equashield Corporation Information
6.1.2 Equashield Description and Business Overview
6.1.3 Equashield Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Equashield Drug Closed System Transmission Product Portfolio
6.1.5 Equashield Recent Developments/Updates
6.2 BD Medical
6.2.1 BD Medical Corporation Information
6.2.2 BD Medical Description and Business Overview
6.2.3 BD Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Medical Drug Closed System Transmission Product Portfolio
6.2.5 BD Medical Recent Developments/Updates
6.3 Teva Medical
6.3.1 Teva Medical Corporation Information
6.3.2 Teva Medical Description and Business Overview
6.3.3 Teva Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Medical Drug Closed System Transmission Product Portfolio
6.3.5 Teva Medical Recent Developments/Updates
6.4 ICU Medical
6.4.1 ICU Medical Corporation Information
6.4.2 ICU Medical Description and Business Overview
6.4.3 ICU Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ICU Medical Drug Closed System Transmission Product Portfolio
6.4.5 ICU Medical Recent Developments/Updates
6.5 Corvida Medical
6.5.1 Corvida Medical Corporation Information
6.5.2 Corvida Medical Description and Business Overview
6.5.3 Corvida Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Corvida Medical Drug Closed System Transmission Product Portfolio
6.5.5 Corvida Medical Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Corporation Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
6.6.4 B. Braun Drug Closed System Transmission Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Closed System Transmission Industry Chain Analysis
7.2 Drug Closed System Transmission Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Closed System Transmission Production Mode & Process
7.4 Drug Closed System Transmission Sales and Marketing
7.4.1 Drug Closed System Transmission Sales Channels
7.4.2 Drug Closed System Transmission Distributors
7.5 Drug Closed System Transmission Customers
8 Drug Closed System Transmission Market Dynamics
8.1 Drug Closed System Transmission Industry Trends
8.2 Drug Closed System Transmission Market Drivers
8.3 Drug Closed System Transmission Market Challenges
8.4 Drug Closed System Transmission Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Closed System Transmission Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drug Closed System Transmission Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drug Closed System Transmission Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drug Closed System Transmission Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drug Closed System Transmission Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drug Closed System Transmission Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drug Closed System Transmission Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drug Closed System Transmission Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drug Closed System Transmission, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Closed System Transmission, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Closed System Transmission, Product Type & Application
Table 12. Global Key Manufacturers of Drug Closed System Transmission, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Closed System Transmission by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Closed System Transmission as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Closed System Transmission Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drug Closed System Transmission Sales by Region (2019-2024) & (K Units)
Table 18. Global Drug Closed System Transmission Sales Market Share by Region (2019-2024)
Table 19. Global Drug Closed System Transmission Sales by Region (2025-2030) & (K Units)
Table 20. Global Drug Closed System Transmission Sales Market Share by Region (2025-2030)
Table 21. Global Drug Closed System Transmission Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drug Closed System Transmission Revenue Market Share by Region (2019-2024)
Table 23. Global Drug Closed System Transmission Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drug Closed System Transmission Revenue Market Share by Region (2025-2030)
Table 25. North America Drug Closed System Transmission Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drug Closed System Transmission Sales by Country (2019-2024) & (K Units)
Table 27. North America Drug Closed System Transmission Sales by Country (2025-2030) & (K Units)
Table 28. North America Drug Closed System Transmission Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drug Closed System Transmission Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drug Closed System Transmission Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drug Closed System Transmission Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drug Closed System Transmission Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drug Closed System Transmission Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drug Closed System Transmission Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drug Closed System Transmission Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drug Closed System Transmission Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drug Closed System Transmission Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drug Closed System Transmission Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drug Closed System Transmission Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Closed System Transmission Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drug Closed System Transmission Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drug Closed System Transmission Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drug Closed System Transmission Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Closed System Transmission Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Closed System Transmission Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drug Closed System Transmission Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drug Closed System Transmission Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drug Closed System Transmission Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drug Closed System Transmission Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drug Closed System Transmission Sales (K Units) by Type (2019-2024)
Table 51. Global Drug Closed System Transmission Sales (K Units) by Type (2025-2030)
Table 52. Global Drug Closed System Transmission Sales Market Share by Type (2019-2024)
Table 53. Global Drug Closed System Transmission Sales Market Share by Type (2025-2030)
Table 54. Global Drug Closed System Transmission Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drug Closed System Transmission Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drug Closed System Transmission Revenue Market Share by Type (2019-2024)
Table 57. Global Drug Closed System Transmission Revenue Market Share by Type (2025-2030)
Table 58. Global Drug Closed System Transmission Price (US$/Unit) by Type (2019-2024)
Table 59. Global Drug Closed System Transmission Price (US$/Unit) by Type (2025-2030)
Table 60. Global Drug Closed System Transmission Sales (K Units) by Application (2019-2024)
Table 61. Global Drug Closed System Transmission Sales (K Units) by Application (2025-2030)
Table 62. Global Drug Closed System Transmission Sales Market Share by Application (2019-2024)
Table 63. Global Drug Closed System Transmission Sales Market Share by Application (2025-2030)
Table 64. Global Drug Closed System Transmission Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drug Closed System Transmission Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drug Closed System Transmission Revenue Market Share by Application (2019-2024)
Table 67. Global Drug Closed System Transmission Revenue Market Share by Application (2025-2030)
Table 68. Global Drug Closed System Transmission Price (US$/Unit) by Application (2019-2024)
Table 69. Global Drug Closed System Transmission Price (US$/Unit) by Application (2025-2030)
Table 70. Equashield Corporation Information
Table 71. Equashield Description and Business Overview
Table 72. Equashield Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Equashield Drug Closed System Transmission Product
Table 74. Equashield Recent Developments/Updates
Table 75. BD Medical Corporation Information
Table 76. BD Medical Description and Business Overview
Table 77. BD Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. BD Medical Drug Closed System Transmission Product
Table 79. BD Medical Recent Developments/Updates
Table 80. Teva Medical Corporation Information
Table 81. Teva Medical Description and Business Overview
Table 82. Teva Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Medical Drug Closed System Transmission Product
Table 84. Teva Medical Recent Developments/Updates
Table 85. ICU Medical Corporation Information
Table 86. ICU Medical Description and Business Overview
Table 87. ICU Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. ICU Medical Drug Closed System Transmission Product
Table 89. ICU Medical Recent Developments/Updates
Table 90. Corvida Medical Corporation Information
Table 91. Corvida Medical Description and Business Overview
Table 92. Corvida Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Corvida Medical Drug Closed System Transmission Product
Table 94. Corvida Medical Recent Developments/Updates
Table 95. B. Braun Corporation Information
Table 96. B. Braun Description and Business Overview
Table 97. B. Braun Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. B. Braun Drug Closed System Transmission Product
Table 99. B. Braun Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Drug Closed System Transmission Distributors List
Table 103. Drug Closed System Transmission Customers List
Table 104. Drug Closed System Transmission Market Trends
Table 105. Drug Closed System Transmission Market Drivers
Table 106. Drug Closed System Transmission Market Challenges
Table 107. Drug Closed System Transmission Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Closed System Transmission
Figure 2. Global Drug Closed System Transmission Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Closed System Transmission Market Share by Type in 2023 & 2030
Figure 4. Closed Vial Access Device Product Picture
Figure 5. Closed Syringe Safety Device Product Picture
Figure 6. Closed Bag/Line Access Device Product Picture
Figure 7. Global Drug Closed System Transmission Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Drug Closed System Transmission Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global Drug Closed System Transmission Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Drug Closed System Transmission Market Size (2019-2030) & (US$ Million)
Figure 14. Global Drug Closed System Transmission Sales (2019-2030) & (K Units)
Figure 15. Global Drug Closed System Transmission Average Price (US$/Unit) & (2019-2030)
Figure 16. Drug Closed System Transmission Report Years Considered
Figure 17. Drug Closed System Transmission Sales Share by Manufacturers in 2023
Figure 18. Global Drug Closed System Transmission Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Drug Closed System Transmission Players: Market Share by Revenue in 2023
Figure 20. Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Drug Closed System Transmission Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Drug Closed System Transmission Sales Market Share by Country (2019-2030)
Figure 23. North America Drug Closed System Transmission Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Drug Closed System Transmission Sales Market Share by Country (2019-2030)
Figure 27. Europe Drug Closed System Transmission Revenue Market Share by Country (2019-2030)
Figure 28. Germany Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Drug Closed System Transmission Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Drug Closed System Transmission Revenue Market Share by Region (2019-2030)
Figure 35. China Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Drug Closed System Transmission Sales Market Share by Country (2019-2030)
Figure 46. Latin America Drug Closed System Transmission Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Drug Closed System Transmission Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Drug Closed System Transmission Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Drug Closed System Transmission Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Drug Closed System Transmission by Type (2019-2030)
Figure 56. Global Revenue Market Share of Drug Closed System Transmission by Type (2019-2030)
Figure 57. Global Drug Closed System Transmission Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Drug Closed System Transmission by Application (2019-2030)
Figure 59. Global Revenue Market Share of Drug Closed System Transmission by Application (2019-2030)
Figure 60. Global Drug Closed System Transmission Price (US$/Unit) by Application (2019-2030)
Figure 61. Drug Closed System Transmission Value Chain
Figure 62. Drug Closed System Transmission Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
